Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
06/17/1981 | EP0030496A1 Thiolated polypeptidic compound coming from a fragment of tetanic toxine, process for obtaining it and its applications |
06/17/1981 | EP0030450A2 Hybrid cell line for producing complement-fixing, monoclonal antibody to human suppressor T cells, antibody, method of preparation of this antibody, diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody |
06/17/1981 | EP0030449A2 Hybrid cell line for producing monoclonal antibody to human thymocyte antigen, antibody, method of preparation of this antibody, diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody |
06/16/1981 | US4273865 Insolubilized biochemical materials |
06/16/1981 | US4273762 Lyophilization process for live viral compositions |
06/16/1981 | US4273756 Immunoassay for class specific antibodies |
06/16/1981 | CA1103157A1 Method of producing antibodies |
06/16/1981 | CA1103156A1 Method of producing tumor antibodies |
06/16/1981 | CA1103155A1 Improved acellular vaccines containing capsular polysaccharides |
06/10/1981 | EP0030199A2 Lyophilization process for live viral compositions |
06/10/1981 | EP0030172A1 Process for preparing rhesus antigen, medicine and pharmaceutical compositions containing the antigen and administration forms |
06/10/1981 | EP0030166A1 Vaccine composition for dental caries |
06/10/1981 | EP0030063A2 Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strains |
06/09/1981 | US4272521 Purified immune serum globulin |
06/09/1981 | US4272433 Polypeptides, protein carriers |
06/09/1981 | CA1102696A1 Vaccine and method for immunotherapy of neoplastic disease |
06/02/1981 | US4271147 Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same |
06/02/1981 | US4271146 Methods of using Chlamydia vaccine for preventing and treating bovine and ovine diseases |
06/02/1981 | US4271145 Process for producing antibodies to hepatitis virus and cell lines therefor |
06/02/1981 | US4271069 Beta-hCG preparation and method |
05/27/1981 | EP0029191A1 Protein PP 11, process for its isolation and its use |
05/27/1981 | EP0029063A1 Detection of non-a, non-b hepatitis associated antigen |
05/27/1981 | EP0029047A1 Combined inactivated vaccine, ready for administration and process for the preparation of such vaccine, active against egg production drop caused by adeno like viruses and against diseases caused by reo viruses |
05/26/1981 | US4269825 New glycoprotein and process for isolating it |
05/26/1981 | US4269821 Injecting submicroscopic particles of polymerized styrene or an acrylic monomer having adsorbed insulin in a liquid; vaccines; immunology; time-release agents |
05/26/1981 | US4269765 Immune serum for diagnosis of cancer and preparation thereof |
05/26/1981 | US4269764 Water-soluble polymers for biological injections by polymerizing an antigen and glutar aldehyde |
05/20/1981 | EP0028987A2 Process for the in vitro culture of hepatitis B virus |
05/20/1981 | EP0028902A1 Method for the preferential formation of hybrid cells making a desired antibody |
05/20/1981 | EP0028815A2 The use of ricin and a pharmaceutical composition containing the same for increasing the immune response |
05/20/1981 | EP0028814A2 Use of abrin for the manufacture of an immunopentiator |
05/20/1981 | EP0028804A2 Vaccine and method for its preparation |
05/20/1981 | EP0028795A2 Valproic acid conjugates and antibodies thereto |
05/19/1981 | US4268435 Chorionic gonadotropin derived antigen for early pregnancy test and contraceptive vaccine |
05/19/1981 | CA1101333A1 Preparation process of a protein concentrate containing immunological factors of lactic origin |
05/13/1981 | EP0028567A2 Method of preparing hepatitis B surface antigen |
05/13/1981 | EP0028563A1 Stabilizer for liquid vaccines and liquid vaccine containing said stabilizer |
05/13/1981 | EP0028332A1 Beta-galactosyl-umbelliferone-labeled protein and polypeptide conjugates, and N-substituted 7-beta-galactosylcumarin-3-carboxamides |
05/12/1981 | US4267235 Labels; immunoassay; crosslinking |
05/12/1981 | US4267234 Polyglutaraldehyde synthesis and protein bonding substrates |
05/12/1981 | US4267170 Methods of using chlamydia vaccine for preventing and treating bovine diseases |
05/12/1981 | CA1100872A1 Method of producing intravenously injectable gamma globulin |
05/12/1981 | CA1100869A1 Use of tri-iodo thyronine bonded to an enzyme in the determination of the concentration of tri-iodo thyronine |
05/06/1981 | EP0028196A2 Glycolipid derivatives, their preparation and compositions comprising them |
05/06/1981 | EP0028172A2 Anticolibacillary animal vaccine, preparation, application and used escherichia coli strains |
05/06/1981 | EP0028132A2 Method of passively adsorbing immuno-reactive haptens to solid phases |
05/06/1981 | EP0028092A2 A radiolabeled antibody composition, a kit for making same and a cancer or tumor-detection kit employing the composition |
05/06/1981 | EP0027794A1 New and improved methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis |
05/05/1981 | US4265873 Method for typing human leukocyte antigens |
04/30/1981 | WO1981001153A1 Eucaryote cells having a certain and concentration |
04/30/1981 | WO1981001101A1 Improvements in or relating to vaccines |
04/29/1981 | EP0027664A1 Use of the PP5 protein, its derivatives or the antibodies directed against that protein in contraception or in disruption of pregnancy |
04/29/1981 | EP0027662A1 Eucaryotic cells and eucaryotic protoplasts with an amount of naked DNA introduced by lipid vesicles, process for their preparation and their use in the preparation of gene products |
04/29/1981 | EP0027657A2 Process for producing antibodies to hepatitis virus and cell lines therefor |
04/29/1981 | EP0027631A1 Flavin adenine dinucleotide-labeled protein and polypeptide conjugates |
04/28/1981 | US4264764 Meningitis vaccine |
04/28/1981 | US4264588 Vaccine for Clostridium perfringens type E enterotoxemia of rabbits |
04/28/1981 | US4264587 Vaccine for preventing persistent feline leukemia viremia in cats |
04/28/1981 | US4264571 Radioimmunoassay of thymosin α1 |
04/28/1981 | CA1100039A2 Hepatitis b antigen |
04/28/1981 | CA1100038A2 Hepatitis b antigen |
04/22/1981 | EP0027347A1 Feline infectious peritonitis virus, its preparation and vaccines containing it |
04/22/1981 | EP0027249A1 Process for the preparation of influenza A virus vaccinating strains, vaccinating strain and vaccine containing it |
04/21/1981 | CA1099635A1 Atoxic, immunogenic product of tetanus toxin |
04/21/1981 | CA1099634A1 Vaccine stabilizer |
04/15/1981 | EP0027088A1 Allergenic composition and process for its preparation |
04/14/1981 | US4261975 Outer membrane of influenza virus attached to liposome using cationic surfactant |
04/14/1981 | US4261974 Valproic acid immunogen conjugates and antibodies thereto |
04/14/1981 | US4261973 Suppression of production of reaginic antibodies by injection of conjugate allergen with water-soluble polymer |
04/14/1981 | CA1099258A1 Antigen-protein complex for blocking allergic reactions |
04/08/1981 | EP0026209A1 A vaccine for combatting pleuropneumonia in pigs, and a process and a substrate for the aerobic fermentation of haemophilus pleuropneumoniae |
04/07/1981 | US4260602 Hapten polysaccharide conjugate medicaments and method of use |
04/02/1981 | WO1981000812A1 Vaccines from taxonomically similar organisms |
04/01/1981 | EP0025842A2 Peptides, process for their preparation, their pharmaceutical compositions and their intermediates |
03/31/1981 | US4259324 Derivatives of thiopyranoses |
03/31/1981 | US4259233 β-Galactosyl-umbelliferone-labeled protein and polypeptide conjugates |
03/31/1981 | US4259232 Flavin adenine dinucleotide-labeled protein and polypeptide conjugates |
03/31/1981 | CA1098515A1 Immunising and anti-infectious adjuvant agents constituted by esters of the n-acetyl-muramyl-l- alanyl-d-isoglutamine |
03/25/1981 | EP0025745A1 Process for propagating human hepatitis A virus in in vitro cell culture |
03/25/1981 | EP0025719A2 Gamma-globulin preparation for intravenous administration, process for production thereof and process for preparation of gamma-globulin of low anticomplementary activity |
03/25/1981 | EP0025495A1 Lipophilic muramyl peptides, processes for their preparation and their use |
03/24/1981 | US4258029 Synthetic adjuvants for stimulation of antigenic responses |
03/24/1981 | CA1098032A1 Solid phase assay of non-human antibody |
03/24/1981 | CA1098014A1 Method of indicating rheumatoid factors |
03/18/1981 | EP0025379A2 Process for the preparation of suspensions or stable powders of stable microcapsules having a variable porosity, and products so obtained |
03/18/1981 | EP0025275A2 Immunoglobulin-containing composition containing an aggregation preventing or aggregate dissociating agent for the immunoglobulin, and process for preparation thereof |
03/18/1981 | EP0025116A1 Method of testing the inactivity of inoculates and harmlessness of blood products as well as the activity of chemotherapeutics or disinfectants against virus hepatitis and method for isolation of hepatitis virus antigen |
03/17/1981 | US4256735 Immunologically active dipeptidyl saccharides and methods of preparation |
03/17/1981 | US4256732 Oxidative rearrangement and ring scission |
03/17/1981 | US4256631 Purification by fractional precipitation |
03/17/1981 | US4256629 Antigen for early pregnancy test and contraceptive vaccine |
03/11/1981 | EP0024956A2 Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype, method of preparing them and bacterial strains used in them |
03/11/1981 | EP0024541A2 Vaccine for preventing persistent feline leukemia viremia in cats and process for preparing it |
03/11/1981 | EP0024493A2 Multivalent pneumococcal vaccine |
03/10/1981 | US4255537 Polymeric immunoregulatory agents containing half-amide/half carboxy/imide groups |
03/10/1981 | US4255520 Process for the preparation of a rabies vaccine and vaccine obtained by this process |
03/10/1981 | CA1097219A1 Respiratory syncytial vaccine |
03/10/1981 | CA1097218A1 Hepatitis b surface antigen |
03/05/1981 | WO1981000577A1 Nucleotidic sequence coding the surface antigen of the hepatitis b virus,vector containing said nucleotidic sequence,process allowing the obtention thereof and antigen obtained thereby |
03/05/1981 | WO1981000517A1 Snake venom neurotoxin prophylaxis and therapy for poisonous organophosphates |